Research & Development

Almirall launches new call to find innovative therapies for skin diseases

The new AlmirallShare call focuses on exploring partnerships to maximize the value of preclinical and clinical stage assets for patients suffering from a dermatological condition

Breaking News

Medicines Discovery Catapult and ZEISS set sights on advancing microscopy in drug discovery

Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early development of complex medicines by harnessing...

BioIVT acquires Cypex, a leading manufacturer of drug-metabolising enzymes

Cypex’s recombinant xenobiotic metabolising enzymes complement BioIVT’s extensive portfolio of hepatocytes and related hepatic products for drug re...

SGS Quay Pharma receives Queen’s Award for industry

Leading pharmaceutical contract development and manufacturing organisation (CDMO) SGS Quay Pharma has received its Queen’s Award for Enterprise

Nanoparticles enable effective drug delivery

Effective drug delivery ensures that therapeutic agents reach their intended destination, releasing the active pharmaceutical ingredient at the tar...

Societal CDMO wins tech transfer and production contract for HIV drug candidate

The small molecule CDMO has been selected to provide services to support the ongoing clinical development of a novel drug candidate in Europe

Scaling CRO capabilities with smart finance

For more than 25 years, the trend of outsourcing R&D activities in the pharmaceutical industry has been gaining traction.<sup>1</sup> Driven by the...

Tackling drug resistance in immuno-oncology: the role of combinational therapy

The application of immunotherapy for cancer treatment has burgeoned during the past decade, transforming the way we manage certain types of cancer....

Manufacturing Chemist LIVE 2022 in review (part I)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and excit...

ISPE Pharmaceutical Engineering article “AI’s Promise for ATMPs” honoured with 2022 APEX Award

ISPE has been honoured as the winner of a 2022 "APEX Award for Publication Excellence in the Technical & Technology Writing" category for the artic...

Have you got screen fatigue?

Read Manufacturing Chemist in print, at your leisure

Manufacturing Chemist LIVE 2022 in review (part II)

Taking a front row seat during the two-day pharmaceutical conference in Birmingham, UK, Dr Kevin Robinson reports on what’s new, emerging and excit...

Native mass spectrometry as a drug discovery engine

Using mass spectrometry to characterise and screen large intact protein targets, captured directly in their native state, is making waves as a diff...

Almirall launches new call to find innovative therapies for skin diseases

The new AlmirallShare call focuses on exploring partnerships to maximize the value of preclinical and clinical stage assets for patients suffering...

Overcoming bioanalytical hurdles in the pharma and life sciences sector

A new era of innovation and advancement in drug design, and modalities such as cell and gene therapies (CGTs), have led to the development of promi...

CN Bio opens new laboratory facilities to extend OOC contract research services capabilities

State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for organ-on-a-chip research services

Navigating the maelstrom of M&A activity: what do CDMOs do next?

In an increasingly competitive market for contract service providers, do outsourcing companies acquire, grow or take a strategically vertical or ho...